My research focuses on molecular imaging and targeted radiotherapy. Utilization of radioactive peptides that bind to tumor-selective receptors has advantages for both of these applications. My group has evaluated peptides that bind to the G-coupled protein receptors, gastrin-releasing peptide receptor (GRPR) and somatostatin receptor subtype 2 (SSTR2). We have also used somatostatin analogues to image SSTR2 after gene transfer with adenoviral vector encoding for SSTR2 (AdSSTR2).
- 1991: MA, chemistry, Washington University, St. Louis
- 1995: PhD, inorganic chemistry, Washington University
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.